An integrated national scale SARS-CoV-2 genomic surveillance network

Abstract

The Coronavirus Disease 2019 (COVID-19) Genomics UK Consortium (COG-UK) was launched in March, 2020, with £20 million support from UK Research and Innovation, the UK Department of Health and Social Care, and Wellcome Trust. The goal of this consortium is to sequence severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for up to 230 000 patients, health-care workers, and other essential workers in the UK with COVID-19, which will help to enable the tracking of SARS-CoV-2 transmission, identify viral mutations, and integrate with health data to assess how the viral genome interacts with cofactors and consequences of COVID-19.

Cited by papers we hold 9

• Prevalence of persistent SARS-CoV-2 in a large community surveillance study · 2024
  No notice
• Pandemic-scale phylogenomics reveals the SARS-CoV-2 recombination landscape · 2022
  No notice
• A global resource for genomic predictions of antimicrobial resistance and surveillance of Salmonella Typhi at pathogenwatch · 2021
  No notice
• Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK · 2021
  No notice
• SARS-CoV-2 within-host diversity and transmission · 2021
  No notice
• Patterns of within-host genetic diversity in SARS-CoV-2 · 2021
  No notice
• Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence · 2021
  No notice
• Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation · 2020
  No notice
• Stability of SARS-CoV-2 phylogenies · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.